Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sander van Doorn

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Heart (British Cardiac Society)|March 18, 2018
Opportunistic screening for heart failure with natriuretic peptides in patients with atrial fibrillation: a meta-analysis of individual participant data of four screening studiesSander van Doorn, Geert-Jan Geersing, Rogier F Kievit, et al.
Plos One|October 19, 2023
Integrated care in patients with atrial fibrillation- a predictive heterogeneous treatment effect analysis of the ALL-IN trialEmmy M Trinks-Roerdink, Geert-Jan Geersing, Carline J van den Dries, et al.
European Heart Journal|March 1, 2020
Integrated management of atrial fibrillation in primary care: results of the ALL-IN cluster randomized trialCarline J van den Dries, Sander van Doorn, Frans H Rutten, et al.
Journal of Clinical Epidemiology|May 10, 2024
Don't be misled: 3 misconceptions about external validation of clinical prediction modelsHannah M la Roi-Teeuw, Florien S van Royen, Anne de Hond, et al.
BMJ Open|January 1, 2020
Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trialLinda P T Joosten, Sander van Doorn, Arno W Hoes, et al.
Journal of Thrombosis and Haemostasis : JTH|May 21, 2020
Diagnosing deep vein thrombosis in cancer patients with suspected symptoms: An individual participant data meta-analysisToshihiko Takada, Sander van Doorn, Sameer Parpia, et al.
Cell|November 15, 2016
EGFR Dynamics Change during Activation in Native Membranes as Revealed by NMRMohammed Kaplan, Siddarth Narasimhan, Cecilia de Heus, et al.
Circulation|August 27, 2023
Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled TrialLinda P T Joosten, Sander van Doorn, Peter M van de Ven, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Heart (British Cardiac Society)|March 18, 2018
Opportunistic screening for heart failure with natriuretic peptides in patients with atrial fibrillation: a meta-analysis of individual participant data of four screening studiesSander van Doorn, Geert-Jan Geersing, Rogier F Kievit, et al.
Plos One|October 19, 2023
Integrated care in patients with atrial fibrillation- a predictive heterogeneous treatment effect analysis of the ALL-IN trialEmmy M Trinks-Roerdink, Geert-Jan Geersing, Carline J van den Dries, et al.
European Heart Journal|March 1, 2020
Integrated management of atrial fibrillation in primary care: results of the ALL-IN cluster randomized trialCarline J van den Dries, Sander van Doorn, Frans H Rutten, et al.
Journal of Clinical Epidemiology|May 10, 2024
Don't be misled: 3 misconceptions about external validation of clinical prediction modelsHannah M la Roi-Teeuw, Florien S van Royen, Anne de Hond, et al.
BMJ Open|January 1, 2020
Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trialLinda P T Joosten, Sander van Doorn, Arno W Hoes, et al.
Journal of Thrombosis and Haemostasis : JTH|May 21, 2020
Diagnosing deep vein thrombosis in cancer patients with suspected symptoms: An individual participant data meta-analysisToshihiko Takada, Sander van Doorn, Sameer Parpia, et al.
Cell|November 15, 2016
EGFR Dynamics Change during Activation in Native Membranes as Revealed by NMRMohammed Kaplan, Siddarth Narasimhan, Cecilia de Heus, et al.
Circulation|August 27, 2023
Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled TrialLinda P T Joosten, Sander van Doorn, Peter M van de Ven, et al.
Pageof 8